Scout Investments, Inc. Neurocrine Biosciences Inc Transaction History

Scout Investments, Inc.

$3.45 Billion
Q2 2024

A detailed history of Scout Investments, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Scout Investments, Inc. holds 189,870 shares of NBIX stock, worth $22.9 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

189,870

Previous 106,525 78.24%

Holding current value

$22.9 Million

Previous $14.7 Million 77.93%

% of portfolio

0.76%

Previous 0.39%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$130.86 - $143.19 $10.9 Million - $11.9 Million	83,345 Added 78.24%	189,870 $26.1 Million
Q1 2024 May 09, 2024	SELL	$130.4 - $143.74 $20.2 Million - $22.3 Million	-155,093 Reduced 59.28%	106,525 $14.7 Million
Q4 2023 Feb 13, 2024	SELL	$106.07 - $132.76 $11.1 Million - $13.8 Million	-104,199 Reduced 28.48%	261,618 $34.5 Million
Q3 2023 Nov 09, 2023	BUY	$94.02 - $117.1 $1.3 Million - $1.62 Million	13,870 Added 3.94%	365,817 $41.2 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $19.8 Million - $23.2 Million	221,618 Added 170.05%	351,947 $33.2 Million
Q1 2023 May 11, 2023	SELL	$94.11 - $123.02 $2.71 Million - $3.54 Million	-28,810 Reduced 18.1%	130,329 $13.2 Million
Q4 2022 Jan 23, 2023	SELL	$106.72 - $127.06 $7.87 Million - $9.38 Million	-73,785 Reduced 31.68%	159,139 $0
Q3 2022 Oct 18, 2022	SELL	$92.03 - $107.81 $800,384 - $937,623	-8,697 Reduced 3.6%	232,924 $24.7 Million
Q1 2022 Apr 14, 2022	SELL	$72.45 - $94.81 $545,838 - $714,298	-7,534 Reduced 3.02%	241,621 $22.7 Million
Q4 2021 Jan 14, 2022	SELL	$79.65 - $106.22 $442,774 - $590,476	-5,559 Reduced 2.18%	249,155 $21.2 Million
Q3 2021 Oct 13, 2021	SELL	$86.18 - $99.03 $336,446 - $386,613	-3,904 Reduced 1.51%	254,714 $24.4 Million
Q2 2021 Jul 23, 2021	BUY	$89.43 - $102.27 $5.03 Million - $5.75 Million	56,228 Added 27.78%	258,618 $25.2 Million
Q1 2021 Apr 09, 2021	SELL	$87.57 - $119.4 $2.67 Million - $3.64 Million	-30,445 Reduced 13.08%	202,390 $19.7 Million
Q4 2020 Jan 12, 2021	SELL	$86.91 - $108.33 $169,039 - $210,701	-1,945 Reduced 0.83%	232,835 $22.3 Million
Q3 2020 Oct 13, 2020	BUY	$96.16 - $135.15 $5.87 Million - $8.25 Million	61,059 Added 35.15%	234,780 $22.6 Million
Q2 2020 Jul 14, 2020	BUY	$85.09 - $130.36 $14.8 Million - $22.6 Million	173,721 New	173,721 $21.2 Million

Others Institutions Holding NBIX

# of Institutions

623

Shares Held

95.4M

Call Options Held

661K

Put Options Held

221K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scout Investments, Inc. with notifications on news.

Account

Scout Investments, Inc. Neurocrine Biosciences Inc Transaction History